Answers are grounded in this paper and cite their sources.
BACKGROUND AND OBJECTIVES: Emerging evidence indicates that amyotrophic lateral sclerosis (ALS) shares genetic architecture with other neurologic disorders, whose causal variants may be overlooked by targeted sequencing. Here, we evaluated the occurrence of pathogenic variants in genes linked to adult-onset neurologic disorders among individuals with ALS. METHODS: expansions (>30 repeats) were routinely screened by fragment analysis and repeat-primed PCR. Beyond established ALS pathways, enrichment was observed in mitochondrial, metabolic, and proteostasis pathways (false discovery rate ≤0.05). DISCUSSION: Although the absence of a control cohort limits assessment of variant enrichment, the identification of pathogenic or likely pathogenic variants in genes associated with adult-onset neurologic disorders other than ALS/FTD in patients with ALS supports the inclusion of broader gene panels to advance precision medicine in ALS.
No takes yet. Share an insight, caveat, or question.
Manini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: